Published on 25 Apr 2024 on Simply Wall St. via Yahoo Finance
Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock...
Many investors define successful investing as beating the market average over the long term. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term Anika Therapeutics, Inc. (NASDAQ:ANIK) shareholders, since the share price is down 37% in the last three years, falling well short of the market return of around 14%.
Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.